Printer Friendly

Active Biotech AB and PowderJect Pharmaceuticals Plc settle dispute.

NORDIC BUSINESS REPORT-1 April 2004-Active Biotech AB and PowderJect Pharmaceuticals Plc settle dispute(C)1994-2004 M2 COMMUNICATIONS LTD

The Swedish company Active Biotech AB said on Thursday (1 April) that it had settled a dispute with the United Kingdom company PowderJect Pharmaceuticals Plc, part of the US group Chiron Corporation Inc.

The dispute related to certain guarantees in the agreement for PowderJect Pharmaceuticals' acquisition of SBL Vaccin AB from Active Biotech in 2001.

Under the settlement agreement PowderJect Pharmaceuticals has agreed to withdraw its USD20m claim and to waive the disputed guarantees.

For its part Active Biotech has agreed to reduce its milestone payment demand to USD4.5m and to waive all further royalty and milestone payments.

One US dollar (USD) is worth approximately 0.547 British pounds (GBP).

((Comments on this story may be sent to

COPYRIGHT 2004 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nordic Business Report
Article Type:Brief Article
Geographic Code:4EUUK
Date:Apr 1, 2004
Previous Article:Biolin AB's MediTeam signs new licence agreement with Chinese partner Scienceway Biotechnologies Co.
Next Article:Stolt Offshore SA wins pipelay contracts in Trinidad.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |